Cargando…

1815. Assessment of Therapy Duration for Non-Staphylococcal Gram-Positive Bloodstream Infections

BACKGROUND: The optimal duration of antimicrobial therapy for non-staphylococcal Gram-positive (GP) bloodstream infections (BSIs) remains unknown. The purpose of this study was to evaluate clinical outcomes in patients with short (6-10 days) vs. long (11-21 days) duration of therapy (DOT) for non-st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gould, Alyssa P, Crawford, Robert L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752675/ http://dx.doi.org/10.1093/ofid/ofac492.1445

Ejemplares similares

191. Oral Antibiotic Step-Down Therapy for Non-Staphylococcal Gram-Positive Bloodstream Infections
por: Gandhi, Kelvin, et al.
Publicado: (2021)

131. Duration of Therapy for the Treatment of Gram-Negative Bloodstream Infections
por: Shulder, Stephanie, et al.
Publicado: (2019)

1815. Clinical Characteristics of Infections due to Staphylococcus Lugdunensis Compared to Other Staphylococcal Infections
por: Harb, Souad Bou, et al.
Publicado: (2023)

Effectiveness of oral antibiotics for definitive therapy of non-Staphylococcal Gram-positive bacterial bloodstream infections
por: Quinn, Nicholas J., et al.
Publicado: (2019)

1043. Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections
por: Rac, Hana, et al.
Publicado: (2018)

1010. Effectiveness of Oral Antibiotics for Definitive Therapy of Gram-Positive Bloodstream Infections
por: Roshdy, Danya, et al.
Publicado: (2018)

198. Comparison of Standard versus Extended Treatment Duration for Gram-negative Bloodstream Infections with Obstructing Nephrolithiasis or Urolithiasis
por: Harpenau, Tara L, et al.
Publicado: (2023)

2174. Comparison of the Verigene® and the ePlex® Blood Culture Identification Panels for Gram-Positive and Gram-Negative Bloodstream Infections
por: Johnson, J Kristie, et al.
Publicado: (2019)

1841. Incidence and Predictors of Complications in Gram Negative Bloodstream Infection
por: Mondal, Utpal, et al.
Publicado: (2022)

147. Non-Fermenting Gram-Negative Bloodstream Infection: A Multicenter Retrospective Cohort Study
por: Pascale, Renato, et al.
Publicado: (2019)

Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections
por: Leli, Christian, et al.
Publicado: (2015)

186. Evaluating Clinical Outcomes for Treatment of Staphylococcal Bloodstream Infection in Patients with Febrile Neutropenia
por: Aleissa, Muneerah M, et al.
Publicado: (2021)

2308. The Prevalence of Antiseptic Tolerance Genes Among Gram-Positive Bloodstream Pathogens in Children
por: Sommer, Lauren, et al.
Publicado: (2018)

222. Bloodstream Infections by Gram(−) Bacteria in Kidney Transplant Patients: Risk Factors, Incidence and Outcome; Bloodstream Infections by Gram(−) Bacteria in Kidney Transplant Patients: Risk Factors, Incidence and Outcome
por: Tsikala Vafea, Maria, et al.
Publicado: (2019)

224. Clinical Relevance of Antibiotic Tolerance in Recurrent Gram-negative Bloodstream Infections
por: Parsons, Joshua B, et al.
Publicado: (2023)

906. Impact of Accelerate Rapid Diagnostic Technology on Time to Optimal Antimicrobial Therapy in Gram Negative Bloodstream Infection
por: Jung, Hye Lim, et al.
Publicado: (2022)

59. Risk Factors for Recurrent Gram-Negative Bacterial Bloodstream Infections
por: Bock, Andrew J, et al.
Publicado: (2021)

254. Genomic diversity of Gram-negative Bacilli from Bloodstream Infections in Hospitalized Children
por: Blumenthal, Jennifer, et al.
Publicado: (2023)

321. Assessing the Role of Daptomycin as Antibiotic Therapy for Staphylococcal Prosthetic Joint Infection
por: Miller, Andy, et al.
Publicado: (2018)

166. Comparison of Oral Fluoroquinolones to Alternative Oral Agents for Definitive Step-Down Therapy in Gram-Negative Bloodstream Infections
por: Cho, Christian Y, et al.
Publicado: (2019)

850. Outcomes of Patients Discharged on Parenteral Ceftriaxone Compared with Oxacillin or Cefazolin in Methicillin-susceptible Staphylococcal aureus (MSSA) Bloodstream Infections
por: Erik Connor, Lee, et al.
Publicado: (2019)

Survey of infectious diseases providers reveals variability in duration of antibiotic therapy for the treatment of Gram-negative bloodstream infections
por: Thaden, Joshua T., et al.
Publicado: (2022)

Gram-Negative Polymicrobial Bloodstream Infections and Clinical Decision Making with a Microarray Testing System
por: Claeys, Kimberly, et al.
Publicado: (2017)

141. Use of Rapid Diagnostic Testing in Gram-negative Bloodstream Infections with and without Antimicrobial Stewardship
por: Claeys, Kimberly C, et al.
Publicado: (2019)

Cefepime-Zidebactam (WCK 5222) Activity Tested against Gram-negative Organisms Causing Bloodstream Infections Worldwide
por: Sader, Helio S, et al.
Publicado: (2017)

Broad In Vitro Activity Analysis of Tedizolid Compared with Other Agents against a Global Collection of Gram-Positive Isolates Causing Bloodstream Infections (2014–2016)
por: Mendes, Rodrigo E, et al.
Publicado: (2017)

2334. Risk Factors of Multidrug-Resistant Gram-Negative Bacterial Bloodstream Infections in Children’s Hospitals in Japan
por: Aizawa, Yuta, et al.
Publicado: (2018)

212. Effectiveness of Empirical Piperacillin/tazobactam Compared to Cefepime for Bloodstream Infection Caused by Gram-Negative Bacilli
por: Ho Lee, Young, et al.
Publicado: (2023)

Service Notes from the Great War, 1793—1815
por: Crawford, D. G.
Publicado: (1905)

205. Evaluating the Time to Oral Step-Down Therapy for Gram-Negative Bloodstream Infections Associated with a Genitourinary Source
por: Mulvey, Nicole, et al.
Publicado: (2021)

715 Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections
por: Brigmon, Matthew, et al.
Publicado: (2014)

177. Clinical Outcomes of Daptomycin vs. Anti-Staphylococcal β-Lactams in Definitive Treatment of Methicillin-Susceptible Staphylococcus aureus (MSSA) Bloodstream Infections
por: Agnello, Sydney, et al.
Publicado: (2019)

Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections
por: Dambroso-Altafini, Daniela, et al.
Publicado: (2022)

167. Duration of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares PCR Positivity while Receiving Highly Active Anti-Staphylococcal Drugs
por: Wu, Maximillian S, et al.
Publicado: (2023)

203. Evaluating the Impact of Extended-Infusion Beta-Lactam Therapy on Clinical Outcomes and the Subsequent Emergence of Resistance in Adults with Gram-Negative Bloodstream Infections
por: Karaba, Sara M, et al.
Publicado: (2023)

82. Assessment of Clinical Outcomes and Antibiotic Prescribing Patterns Following Implementation of the GenMark ePlex(®) Blood Culture Identification Panel for Gram-positive Bloodstream Infections
por: Wein, Megan, et al.
Publicado: (2021)

2163. Risk Factors for Carbapenem-Resistant Gram-Negative Bloodstream Infections (BSI) in U.S. Hospitals (2010–2015)
por: Cai, Bin, et al.
Publicado: (2018)

960. Clinical impact of follow-up blood cultures in gram-negative bloodstream infections: A validation cohort
por: Thaden, Joshua T, et al.
Publicado: (2023)

195. Reducing Time to Optimal Antimicrobial Therapy (OAT) for Bloodstream Infections (BSI) due to Gram Positive Cocci (GPC) in Chains Using Rapid Diagnostics Paired with Antimicrobial Stewardship (ASP) Efforts
por: Ma, Justin K, et al.
Publicado: (2022)

180. Duration of Therapy and Clinical Outcomes in Adult Oncology Patients with Uncomplicated Coagulase Negative Staphylococcal Bacteremia
por: Fairbanks, Amanda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_218llc1018ab1h7ic3jchd6lq1